Gene · 4481
Papers3,855
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 3,855
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The current advances of lncRNAs in breast cancer immunobiology research. | Front Immunol | 2023 | 37342324 | PubTator, text mining | PubMed |
| Stromal circuits involving tumor-associated macrophages and cancer-associated fibroblasts. | Front Immunol | 2023 | 37342322 | PubTator, text mining | PubMed |
| Relationships between physical and immunological tumor microenvironment in pancreatic ductal adenocarcinoma. | Cancer Sci | 2023 | 37337413 | PubTator, text mining | PubMed |
| Cells in the polyaneuploid cancer cell (PACC) state have increased metastatic potential. | Clin Exp Metastasis | 2023 | 37326720 | PubTator, text mining | PubMed |
| A clinicopathological analysis of supratentorial ependymoma, ZFTA fusion-positive: utility of immunohistochemical detection of CDKN2A alterations and characteristics of the immune microenvironment. | Brain Tumor Pathol | 2023 | 37322295 | PubTator, text mining | PubMed |
| Microglial cell response to experimental periodontal disease. | J Neuroinflammation | 2023 | 37316834 | PubTator, text mining | PubMed |
| CD44 is a potential immunotherapeutic target and affects macrophage infiltration leading to poor prognosis. | Sci Rep | 2023 | 37316699 | PubTator, text mining | PubMed |
| Targeting immune checkpoints on tumor-associated macrophages in tumor immunotherapy. | Front Immunol | 2023 | 37313405 | PubTator, text mining | PubMed |
| Effectiveness of Combinational Treatments for Alzheimer's Disease with Human Neural Stem Cells and Microglial Cells Over-Expressing Functional Genes. | Int J Mol Sci | 2023 | 37298510 | PubTator, text mining | PubMed |
| Matrix Metalloproteinase 9 Induced in Esophageal Squamous Cell Carcinoma Cells via Close Contact with Tumor-Associated Macrophages Contributes to Cancer Progression and Poor Prognosis. | Cancers (Basel) | 2023 | 37296952 | PubTator, text mining | PubMed |
| Predictive Biomarkers of Pathological Response to Neoadjuvant Chemoradiotherapy for Locally Advanced Soft Tissue Sarcomas. | Cancers (Basel) | 2023 | 37296922 | PubTator, text mining | PubMed |
| PDAC, the Influencer Cancer: Cross-Talk with Tumor Microenvironment and Connected Potential Therapy Strategies. | Cancers (Basel) | 2023 | 37296886 | PubTator, text mining | PubMed |
| Novel ultrasound techniques in the identification of vulnerable plaques-an updated review of the literature. | Front Cardiovasc Med | 2023 | 37293284 | PubTator, text mining | PubMed |
| Hamster model for post-COVID-19 alveolar regeneration offers an opportunity to understand post-acute sequelae of SARS-CoV-2. | Nat Commun | 2023 | 37277327 | PubTator, text mining | PubMed |
| Immunometabolic reprogramming, another cancer hallmark. | Front Immunol | 2023 | 37275901 | PubTator, text mining | PubMed |
| The increased cfRNA of TNFSF4 in peripheral blood at late gestation and preterm labor: its implication as a noninvasive biomarker for premature delivery. | Front Immunol | 2023 | 37275889 | PubTator, text mining | PubMed |
| NPD1 Plus RvD1 Mediated Ischemic Stroke Penumbra Protection Increases Expression of Pro-homeostatic Microglial and Astrocyte Genes. | Cell Mol Neurobiol | 2023 | 37270727 | PubTator, text mining | PubMed |
| Prognostic impact and gene expression analysis of peri-tumoral alveolar macrophage in resected lung adenocarcinoma. | Cancer Sci | 2023 | 37264761 | PubTator, text mining | PubMed |
| Epigenetic Regulation of Macrophage Polarization in Cardiovascular Diseases. | Pharmaceuticals (Basel) | 2023 | 37259293 | PubTator, text mining | PubMed |
| Analysis of the microglia transcriptome across the human lifespan using single cell RNA sequencing. | J Neuroinflammation | 2023 | 37254100 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4481/papers?page=23